Topic: How To Invest

Dividend Advisor Hotline – Friday, September 3, 2021

Article Excerpt

PFIZER INC., $46.84, New York symbol PFE, is a top pick for 2021. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis). With the March 2021 payment, Pfizer raised your dividend by 2.6%. Investors now receive $0.39 a share instead of $0.38. The new annual rate of $1.56 yields a solid 3.3%. Pfizer has agreed to buy Trillium Therapeutics Inc. (Nasdaq symbol TRIL), which is developing several blood cancer treatments. The company will pay $2.26 billion in cash for Trillium. To put that in context, Pfizer earned $6.05 billion, or $1.07 a share, in the three months ended June 30, 2021. If Trillium shareholders approve, Pfizer expects to complete the purchase in the next few months. Trillium’s products are still in the early development stage, but Pfizer’s expertise should accelerate that process. The company has raised the annual dividend rate each year since 2011. Over the past five…